Mission Policy Highlights

Susan G. Komen Colorado led the passage of two critical pieces of legislation this session – both ensure critical access towards meeting our bold goal!  HB19-1301 eliminates the out-of-pocket costs for initial diagnostic imaging therefore improving access and allowing more timely diagnosis and treatment of breast cancer. HB19-1302 reauthorized the Breast and Cervical Cancer Prevention and Treatment program to ensure that uninsured and underinsured individuals in Colorado will not be forced to delay or forego treatment.

HB19-1301 eliminates the disparity in coverage between screening mammography and diagnostic imaging including, diagnostic mammography, breast ultrasound and breast magnetic resonance imaging (MRI) and ensures individuals at high risk receive coverage for early breast cancer screening.  Required follow-up diagnostic services due to an abnormal mammogram are pivotal in the prevention process.  An estimated 10 percent of screening mammograms required a follow-up diagnostic service.  From an early detection perspective, a screening mammogram would not be considered successful if the follow-up diagnostic imaging were not preformed to identify the abnormality or possible cancer.  The systematic use of breast cancer screening and follow-up diagnostics has led to significant increases in the early detection of breast cancer in the past 20 years.  HB19-1301 eliminates the out-of-pocket costs for initial diagnostic imaging therefore improving access and allowing more timely diagnosis and treatment of breast cancer.

HB19-1302 reauthorized the Breast and Cervical Cancer Prevention and Treatment program to ensure that uninsured and underinsured individuals in Colorado will not be forced to delay or forego treatment.  The Colorado Breast and Cervical Cancer Prevention and Treatment (BCCP) Program provides Medicaid coverage for eligible individuals diagnosed with breast or cervical cancer. To be eligible, individuals must be between the ages of 40 and 65; not have health insurance coverage or be eligible to receive Medicaid; and be at or below 250 percent of the Federal Poverty Level.  The reauthorization is a critical step in meeting our bold goal and reducing the breast cancer mortality rate by 50% by 2026.

Thank you to the bill sponsors Reps. Michaelson Jenet & Buckner and Sen. Winter!